Archived - Important Safety Information On Nefazodone Hci: Severe And Serious Hepatic Events

Nefazodone HCI Recall Summary Nefazodone HCI, an antidepressant medication, is being recalled in Canada due to the risk of severe liver damage and liver failure. This medication affects all Canadian patients who have been prescribed nefazodone. The recall was issued because of documented cases of serious and potentially life-threatening liver problems associated with the drug's use.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2001-06-28

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d8c154cb-ac53-40e4-96c8-7949d63c6f20